← COA library
ATMI Labs — Research. Quality. Results.

Certificate of Analysis

Document · COA-ATMI-24.11-RETATR

Compound

Retatrutide

20 mg · Triple incretin receptor agonist studied for glucose regulation and adiposity.

Metabolic

Batch
ATMI-24.11
Issued
July 29, 2026
Manufactured
USA · ISO 9001:2015
Storage
2–8°C, desiccated, dark
Shelf life
24 months from mfg.
Appearance
White lyophilized powder

Analytical Results

TestMethodSpecificationResult
IdentityLC-MSConfirms sequenceConforms
PurityRP-HPLC (220 nm)≥ 98.0%≥99.2%
Molecular weightESI-MS4731.4 g/mol4731.4 g/mol
Water contentKarl Fischer≤ 8.0%4.2%
Acetate contentIon chromatography≤ 15.0%7.8%
Bacterial endotoxinLAL≤ 5 EU/mg< 0.5 EU/mg
BioburdenUSP <61>≤ 100 CFU/g< 10 CFU/g

Sequence / Structure

GIP / GLP-1 / Glucagon triple agonist

Regulatory

For laboratory research use only. Not for human consumption, diagnostic or therapeutic use. This product is not a drug, food, or cosmetic and must not be misbranded or misrepresented as such.

Released by

Dr. A. Reeves · Quality Assurance

ATMI Labs · QA-ATMI-24.11

ATMI Labs · Quality Assurance · atmilabs.com · Document controlled — do not alter